S
Stockadora

FONAR CORP

CIK: 355019 Filed: June 3, 2026 8-K Acquisition High Impact

Key Highlights

  • Transition from public to private company status
  • Mandatory cash-out of all outstanding shares
  • Secured $35 million in new operational financing
  • Elimination of public reporting and SEC filing requirements

Event Analysis

FONAR CORP: The Company Has Been Acquired

Fonar Corp, a leader in medical imaging famous for its stand-up MRI scanners and diagnostic centers, has officially transitioned from a public company to a private one.

1. What happened?

On June 3, 2026, Fonar Corp completed its merger with "FONAR, LLC" (the Parent). Fonar Corp is no longer an independent public company and now operates as a wholly-owned subsidiary of the Parent.

2. What does this mean for shareholders?

The merger resulted in the cancellation of all outstanding Fonar Corp shares. In exchange, shareholders receive a fixed cash payment for each share held:

  • Common Stock & Class B Common Stock: $19.00 per share.
  • Class C Common Stock: $6.34 per share.
  • Class A Non-voting Preferred Stock: $10.50 per share.

3. Why does this matter?

Fonar is no longer a publicly traded company. The ticker symbol "FONR" has been retired, and the company is no longer required to file regular reports (such as 10-Ks or 10-Qs) with the SEC. You can no longer buy or sell shares of this company on public exchanges.

4. What does this mean for you?

  • Your Investment: Your ownership stake has been converted into cash. You no longer hold an equity interest in the company’s future performance.
  • Brokerage Accounts: If you still see Fonar shares in your account, they are likely in the final stages of settlement. You should see the cash proceeds appear in your account balance shortly. If the funds have not arrived, contact your brokerage firm directly to ask about their specific processing timeline.
  • Transparency: Because the company is now private, it is no longer obligated to share its financial health, sales data, or business challenges with the public. You will no longer be able to track the company’s performance through standard financial reporting.

5. Looking Ahead

This merger marks the end of Fonar’s time as a public entity. The company has secured a $35 million loan from OceanFirst Bank to support its operations under this new private structure.

Practical Takeaway: Since the company is no longer public, there is no longer an opportunity to invest in Fonar Corp. If you were a shareholder, your primary action is to monitor your brokerage account to ensure the merger proceeds have been credited to your balance. If you have questions about the tax implications of this cash-out, it is a good idea to consult with a tax professional.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and does not constitute financial advice. Always check with your brokerage firm regarding the status of your specific holdings and consult a tax professional regarding the impact of this transaction on your personal finances.

Key Takeaways

  • The ticker 'FONR' is retired; public trading has ceased.
  • Shareholders should monitor brokerage accounts for automatic cash settlement.
  • The company is no longer required to disclose financial performance to the public.
  • Consult a tax professional regarding the capital gains implications of the cash-out.

Why This Matters

This event marks the definitive end of Fonar Corp as a publicly traded entity, signaling a permanent shift in the company’s operational trajectory. For shareholders, this transition is a critical turning point; the cancellation of all outstanding shares effectively terminates retail investment opportunities in the firm and removes the ability to track the company’s performance through public financial disclosures. Beyond the immediate cash-out, this event highlights a broader trend of consolidation within the healthcare and medical technology sectors. We have seen a wave of similar transitions recently, including the move to private ownership by Forian Inc. and the acquisition of Select Medical Holdings Corp, both of which underscore a preference for private capital structures over the volatility of public markets. Furthermore, the acquisition of Farmer Brothers Co. by a strategic industry player and the buyout of Kezar Life Sciences, Inc. by Aurinia Pharmaceuticals Inc. demonstrate that even companies facing significant restructuring or clinical challenges are being absorbed into private or larger corporate ecosystems. For Fonar Corp, the $35 million debt injection supporting this merger suggests that the new ownership intends to aggressively restructure or scale operations away from the scrutiny of public shareholders. Investors must now reconcile their brokerage accounts and address the tax consequences of this forced liquidation. As seen with the recent acquisitions of SunOpta Inc. and Penumbra Inc., these transitions often result in a final payout that may not align with long-term growth expectations, making it essential for retail investors to evaluate their cost basis and prepare for the finality of this exit. This move effectively closes the book on Fonar Corp’s public history, leaving shareholders to pivot their capital toward remaining public opportunities.

Financial Impact

All outstanding shares cancelled in exchange for fixed cash payments; company secured a $35 million loan from OceanFirst Bank.

Affected Stakeholders

Investors
Employees
Regulators

Learn More

How to Read an 8-K Filing

Understanding material event disclosures

Understanding SEC Filings & CIK

How to navigate SEC filings

About This Analysis

AI-powered summary derived from the original SEC filing.

How we analyze filings → | About Stockadora →

Document Information

Event Date: June 3, 2026
Processed: June 4, 2026 at 03:08 AM
View Original SEC Filing

AI-Generated Analysis

This analysis is AI-generated from SEC filings. This is educational content, not financial advice. Always consult a financial advisor before making investment decisions.

Back to All Events